{
    "nctId": "NCT05957068",
    "briefTitle": "Breast Cancer Exercise Intervention Study",
    "officialTitle": "Breast Cancer Exercise Intervention Study (BREXINT)",
    "overallStatus": "RECRUITING",
    "conditions": "Early-stage Breast Cancer, Locally Advanced Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 2156,
    "primaryOutcomeMeasure": "Disease-Free Survival (DFS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with histologically or cytologically proven stage 1, 2, or 3 breast cancer\n* Patients who have undergone curative breast surgery\n* Patients who have received (neo)adjuvant chemotherapy (if given) and/or radiotherapy (if given)\n* Females aged 21 years and older\n* \u2264 8 weeks from breast surgery, or the last adjuvant chemotherapy or radiotherapy session, whichever is latest.\n\nExclusion Criteria:\n\n* Cardiovascular, respiratory, musculoskeletal problems that preclude moderate physical activity.\n* Major medical problems that are deemed by the investigator to be unsuitable for enrollment.",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}